Human Cell STR Profiling: Principles, Methods, and Applications in Cell Line Authentication

Human cell STR profiling (Short Tandem Repeat profiling) is the internationally recognized gold standard for human cell line authentication, misidentification detection, and cross-contamination monitoring. By generating a unique DNA fingerprint from a panel of polymorphic STR markers, this technology verifies cell identity, safeguards experimental reproducibility, and satisfies the mandatory authentication requirements of major journals and funding agencies. This article provides a comprehensive technical overview of human cell STR profiling, covering sample requirements, core testing items, methodology, applications, and frequently asked questions.

Technical Overview

Short Tandem Repeats (STRs), also known as microsatellites, are repetitive DNA sequences composed of 2–7 base pair units arranged in tandem at defined genomic loci. The number of repeat units varies considerably among individuals, making STR loci highly polymorphic genetic markers. Because every person—with the exception of monozygotic twins—carries a unique combination of STR alleles, analyzing a standardized panel of these loci produces a DNA fingerprint that serves as a definitive molecular identifier.

Human cell STR profiling applies this principle to cultured human cells and cell lines. By amplifying a validated panel of polymorphic STR markers and comparing the resulting allele profile against reference cell line databases or donor samples, laboratories can confirm cell line identity, detect intra-species cross-contamination, and verify the human origin of a specimen. The method follows internationally recognized standards, including the ANSI/ATCC ASN-0002 standard for the authentication of human cell lines.

The necessity of STR authentication is well established. Published surveys estimate that 15–20% of research cell lines worldwide are misidentified or cross-contaminated, with HeLa cells historically being the most common intruder. Such errors compromise data integrity, waste research resources, and invalidate experimental conclusions. Consequently, the International Cell Line Authentication Committee (ICLAC), major scientific journals, and funding agencies such as the NIH now require documented STR authentication prior to manuscript submission or grant award.

Testing Samples

Cultured Cell Pellets

Actively proliferating cells harvested during logarithmic growth phase are the preferred sample type. A minimum of approximately 1 × 10⁵ cells is recommended, with 1 × 10⁶ cells being ideal. Cells should be washed with sterile PBS to remove serum proteins and culture medium residues, pelleted by centrifugation, and transported at 2–8 °C or frozen for shipment. Both adherent and suspension cell lines are acceptable.

Extracted Genomic DNA

Pre-isolated genomic DNA may be submitted directly. A minimum quantity of 10 ng of high-quality DNA is required, and sample purity should exhibit an A260/A280 ratio between 1.8 and 2.0. DNA should be free of PCR inhibitors such as EDTA, phenol, or excessive salts, and should be shipped cold to prevent degradation.

Cryopreserved Cells and Cell Bank Samples

Frozen vials from master or working cell banks can be tested to verify identity before release or distribution. Cryovials should be shipped on dry ice to maintain sample integrity. Alternatively, a thawed aliquot may be pelleted and submitted as a cell pellet.

Blood, Buccal Swabs, and Tissue Samples

When donor-origin verification is required, peripheral blood collected in EDTA tubes, buccal swabs, or fresh/frozen tissue specimens can be profiled in parallel with the cell line. An exact match between the donor and cell line profiles establishes provenance, which is essential for primary cell isolation, iPSC derivation projects, and ethics documentation.

Testing Items

A comprehensive human cell STR profiling service typically includes the following deliverables:

• Genotyping of 20 or more polymorphic STR loci, including the expanded core markers D1S1656, D2S441, D3S1358, D5S818, D7S820, D8S1179, D10S1248, D12S391, D13S317, D16S539, D18S51, D19S433, D21S11, D22S1045, CSF1PO, FGA, TH01, TPOX, vWA, and SE33 where applicable.
• Amelogenin sex-determination marker analysis to confirm the gender origin (X/Y) of the cell line.
• Cell line identity verification through comparison with authoritative reference databases, including ATCC, DSMZ, Cellosaurus, and the NCBI BioSample STR profile collection.
• Cross-contamination assessment, including detection of mixed allele patterns and the presence of characteristic HeLa cell contamination.
• Confirmation of the human origin of the sample based on successful amplification of human-specific STR loci.
• A full technical report containing the raw electropherogram, the complete allele table, the database matching score, and professional interpretation of the results.

Testing Methods

The standard STR profiling workflow comprises five sequential stages carried out under strict quality control with positive and negative amplification controls.

Genomic DNA Extraction and Quantification

Total genomic DNA is extracted from the submitted cell pellet or specimen using a validated column-based or magnetic bead-based purification method. DNA concentration and purity are measured by fluorometric or spectrophotometric assay to ensure the template meets the input requirements for amplification.

Multiplex PCR Amplification

Target STR loci and the amelogenin marker are simultaneously amplified using a commercial multiplex PCR system with fluorescence-labeled primers. The reaction is optimized to require only nanogram quantities of template DNA, and amplification parameters follow the reagent manufacturer's validated cycling protocol.

Capillary Electrophoresis

Amplified fragments are separated by capillary electrophoresis on a genetic analyzer alongside an internal size standard, enabling precise determination of fragment length for each locus.

Data Analysis and Allele Calling

Specialized genotyping software converts fragment sizes into allele designations at each locus, generating the complete STR profile of the sample. Quality metrics such as peak height balance and signal threshold are evaluated to exclude artifacts.

Database Comparison and Interpretation

The resulting profile is compared against reference cell line databases. According to the ANSI/ATCC ASN-0002 standard, a matching score of 80% or greater indicates that the tested cells are of the same origin as the reference cell line, while scores below 80% indicate the sample is not related to the reference or may represent an unidentified line. Mixed profiles with three or more alleles at multiple loci indicate cross-contamination or a hybrid cell population.

Applications

Human cell STR profiling is a routine quality control requirement across academic research, biopharmaceutical development, and cell resource management:

• Pre-publication authentication required by leading journals in cell and molecular biology, oncology, and pharmacology.
• Identity confirmation of newly received or newly established cell lines prior to initiating experiments.
• Release testing and quality control of master and working cell banks in cell resource centers and biobanks.
• Periodic monitoring of long-term cultures for inter- and intra-species cross-contamination, particularly in laboratories handling multiple human cell lines simultaneously.
• Donor-cell matching for primary cells, stem cell lines, and iPSC derivatives to document lineage provenance.
• Supporting documentation for grant applications, regulatory submissions, patent filings, and compliance with FDA, EMA, and ICH guidance on cell-based products.
• Forensic and clinical laboratory applications requiring human biological material identification and traceability.

FAQ

Q: How many cells or how much DNA is needed for testing?

A: A minimum of approximately 1 × 10⁵ cells or 10 ng of purified genomic DNA is sufficient. Higher quantities improve the robustness of extraction, but STR multiplex PCR is highly sensitive and works reliably with limited material, including low-abundance primary cultures.

Q: How long does STR profiling take?

A: Standard turnaround time is typically 5–10 working days from receipt of the sample, depending on sample type, cell count, and whether database comparison and interpretation are included.

Q: What matching result confirms that a cell line is authentic?

A: Per the ANSI/ATCC ASN-0002 guideline, a match score of 80% or higher against a reference profile confirms identity. An exact 100% match is expected when comparing against the original donor or source profile.

Q: The report shows extra alleles at several loci. What does this mean?

A: The presence of additional alleles beyond the expected one or two per locus suggests cross-contamination by another human cell line, aneuploidy-associated copy number changes, or a mixed culture. Genetic instability and copy number variation are common in transformed cancer cell lines and may explain minor deviations, whereas systematic multi-locus imbalance strongly indicates contamination.

Q: Will the STR profile change with increasing passage number?

A: STR loci are highly stable genomic markers, and profiles remain consistent over extended culture. Minor changes may occasionally appear in genetically unstable tumor lines, but routine passages do not alter the core identity profile.

Q: Can STR profiling detect contamination from non-human species such as mouse cells?

A: Human STR primer sets are species-specific and generally will not amplify non-human loci, so inter-species contamination appears as weak or failed amplification rather than a defined profile. When non-human contamination is suspected, complementary species identification testing such as mitochondrial cytochrome oxidase I (COI) sequencing or species-specific PCR is recommended.

Q: How often should a laboratory perform cell line authentication?

A: Best practice recommends authentication at the following time points: immediately after receiving a new cell line, after thawing a frozen stock, every two months of continuous culture, before publishing data, and whenever unexpected changes in morphology or growth behavior are observed.